Findings reveal delayed surgery outcomes in Hispanic and Latino patients receiving cenobamate for epilepsy evaluation, suggesting barriers to care.
Patients with drug-resistant focal epilepsy undergoing evaluation for epilepsy surgery may benefit from cenobamate. In this study, patients who received cenobamate during the presurgical evaluation were less likely to undergo surgery within 12 months. The delay to surgery identified among Hispanic and Latino patients suggests potential barriers to care in this patient population warranting further investigation.
No takes yet. Share an insight, caveat, or question.
Pellinen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: